A Randomized, Open-label Study to Evaluate the Effect of Daprodustat on Blood Pressure in Subjects With Anemia Associated With Chronic Kidney Disease on Hemodialysis Switched From a Stable Dose of an Erythropoiesis-stimulating Agent
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Jul 2017
At a glance
- Drugs Daprodustat (Primary) ; Epoetin alfa
- Indications Anaemia; Hypertension
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 19 Jul 2017 Planned initiation date changed from 14 Jul 2017 to 21 Jul 2017.
- 12 Jul 2017 Planned initiation date changed from 30 Jun 2017 to 14 Jul 2017.
- 27 Jun 2017 Planned initiation date changed from 23 Jun 2017 to 30 Jun 2017.